Conventional Karyotyping Is Still an Important Prognostic Marker for Myeloma in the Era of R-ISS Staging

被引：0
|
作者：
Soekojo, Cinnie Yentia
Wang, Guomiao
Chen, Yunxin
Casan, Joshua
Wolyncewicz, Grace
Lin, Adeline
Poon, L. M.
Koh, Liang Piu
Tan, Lip Kun
Ooi, Melissa
Liu, Yang
Huang, Xiao-Jun
Spencer, Andrew
Kumar, Sathish
Lu, Jin
Chng, Wee Joo
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3119
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Exploring the molecular biomarker utility of circCCT3 in multiple myeloma: A favorable prognostic indicator, particularly for R-ISS II patients
    Papatsirou, Maria
    Kontos, Christos K.
    Ntanasis-Stathopoulos, Ioannis
    Malandrakis, Panagiotis
    Sideris, Diamantis C.
    Fotiou, Despina
    Liacos, Christine-Ivy
    Gavriatopoulou, Maria
    Kastritis, Efstathios
    Dimopoulos, Meletios A.
    Scorilas, Andreas
    Terpos, Evangelos
    [J]. HEMASPHERE, 2024, 8 (01):
  • [22] The detection of circulating plasma cells may improve the Revised International Staging System (R-ISS) risk stratification of patients with newly diagnosed multiple myeloma
    Galieni, Piero
    Travaglini, Fosco
    Vagnoni, Davide
    Ruggieri, Miriana
    Caraffa, Patrizia
    Bigazzi, Catia
    Falcioni, Sadia
    Picardi, Paola
    Mazzotta, Serena
    Troiani, Emanuela
    Dalsass, Alessia
    Mestichelli, Francesca
    Angelini, Mario
    Camaioni, Elisa
    Maravalle, Denise
    Angelini, Stefano
    Pezzoni, Valerio
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (03) : 542 - 550
  • [23] High-risk disease in newly diagnosed multiple myeloma: beyond the R-ISS and IMWG definitions
    Patrick Hagen
    Jiwang Zhang
    Kevin Barton
    [J]. Blood Cancer Journal, 12
  • [24] Role of Conventional Karyotyping in Multiple Myeloma in the Era of Modern Treatment and FISH Analysis
    Soekojo, Cinnie Yentia
    Wang, Guo-miao
    Chen, Yunxin
    Casan, Joshua
    Wolyncewicz, Grace
    Lin, Adeline
    Poon, Li Mei
    de Mel, Sanjay
    Koh, Liang Piu
    Tan, Lip Kun
    Ooi, Melissa G.
    Nagarajan, Chandramouli
    Liu, Yang
    Lai, Yue-yun
    Hu, Xiao-Jun
    Spencer, Andrew
    Gopalakrishnan, Sathish Kumar
    Lu, Jin
    Chng, Wee Joo
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (08): : E470 - E477
  • [25] DINAMIC PREDICTIVE FACTORS FOR A BETTER STRATIFICATION OF PATIENTS WITH R-ISS II NEWLY DIAGNOSED MULTIPLE MYELOMA
    Offidani, M.
    Corvatta, L.
    Maracci, L.
    Garvey, K.
    Gentili, S.
    More, S.
    Mori, V.
    Leoni, P.
    [J]. HAEMATOLOGICA, 2017, 102 : 778 - 779
  • [26] Cytogenetic Abnormalities and Treatment with New Drugs on Clinical Trials Are Important Prognostic Markers for Myeloma in the Era of ISS and FISH Analysis
    Soekojo, Cinnie Yentia
    Lin, Adeline
    Poon, Michelle
    Koh, Liang Piu
    Tan, Lip Kun
    Ooi, Melissa G.
    Chng, Wee Joo
    [J]. BLOOD, 2016, 128 (22)
  • [27] High-risk disease in newly diagnosed multiple myeloma: beyond the R-ISS and IMWG definitions
    Hagen, Patrick
    Zhang, Jiwang
    Barton, Kevin
    [J]. BLOOD CANCER JOURNAL, 2022, 12 (05)
  • [28] Enhancing the R-ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells
    Gonsalves, Wilson I.
    Jevremovic, Dragan
    Nandakumar, Bharat
    Dispenzieri, Angela
    Buadi, Francis K.
    Dingli, David
    Lacy, Martha Q.
    Hayman, Suzanne R.
    Kapoor, Prashant
    Leung, Nelson
    Fonder, Amie
    Hobbs, Miriam
    Hwa, Yi Lisa
    Muchtar, Eli
    Warsame, Rahma
    Kourelis, Taxiarchis V.
    Russell, Stephen
    Lust, John A.
    Lin, Yi
    Go, Ronald S.
    Siddiqui, Mustaqeem A.
    Kyle, Robert A.
    Gertz, Morie A.
    Rajkumar, S. Vincent
    Kumar, Shaji K.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (03) : 310 - 315
  • [29] EVALUATION OF PROGNOSTIC STAGING SYSTEMS FOR MULTIPLE MYELOMA IN THE ERA OF BORTEZOMIB
    Wee, N.
    Tan, D.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 614 - 614
  • [30] The Bone Marker ICTP Adds to the Prognostic Significance of the ISS in Symptomatic Multiple Myeloma
    Jakob, C.
    Sterz, J.
    Mieth, M.
    Heider, U.
    Kaiser, M.
    Liebisch, P.
    Rademacher, J.
    Mueller, C.
    Sezer, O.
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S54 - S55
12345